Patent ID: 9308244
Filing Date: 2016-04-12
CPC Classification: A61K,A61P

Claim Text:
1. A method of treating a neoplastic disorder in a mammal comprising administering to the mammal a vaccine and sunitinib malate, wherein the vaccine comprises a plurality of isolated tumor associated peptides having the ability to bind to a molecule of the human major histocompatibility complex (MHC) class-I or class-II and the plurality of isolated tumor associated peptides consist of the following peptides: SEQ ID NO:1 (SVASTITGV); SEQ ID NO:2 (VMAGDIYSV); SEQ ID NO:3 (ALADGVQKV); SEQ ID NO:4 (LLGATCMFV); SEQ ID NO:5 (SVFAGVVGV); SEQ ID NO: 6 (ALFDGDPHL); SEQ ID NO:7 (YVDPVITSI); SEQ ID NO:8 (SQDDIKGIQKLYGKRS); SEQ ID NO:9 (STAPPVHNV); and SEQ ID NO:10 (LAALPHSCL).